Qutenza
Payments companies reported to CMS as associated with Qutenza. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Qutenza, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Qutenza
These are the largest totals companies reported as associated with Qutenza. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Adam Teichman | Allentown, PA | Foot & Ankle Surgery | $177,571.41 |
| Mark Coleman | Pikesville, MD | Interventional Pain Medicine | $176,572.90 |
| Alaa Abd-Elsayed | Madison, WI | Pain Medicine | $154,387.39 |
| Michael King | Nashville, TN | Podiatrist | $153,354.08 |
| Gary Graf | Topeka, KS | Nurse Practitioner | $145,069.98 |
| Maged Guirguis | New Orleans, LA | Interventional Pain Medicine | $144,858.63 |
| David Reece | Bethesda, MD | Physical Medicine & Rehabilitation | $129,095.70 |
| Waleed El-Feky | Dallas, TX | Neurology (Psychiatry & Neurology) | $113,923.34 |
| Zohra Hussaini | Kansas City, KS | Family | $104,329.95 |
| James North | Winston Salem, NC | Pain Medicine | $102,182.04 |
Prescribed Qutenza?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.